Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher W Murray

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Journal of Computer-Aided Molecular Design|May 27, 2011
Assessing the lipophilicity of fragments and early hitsPaul N Mortenson, Christopher W Murray
Angewandte Chemie (International Ed. in English)|November 4, 2015
Opportunity Knocks: Organic Chemistry for Fragment-Based Drug Discovery (FBDD)Christopher W Murray, David C Rees
Nature Chemistry|March 8, 2011
The rise of fragment-based drug discoveryChristopher W Murray, David C Rees
Journal of Computer-Aided Molecular Design|March 26, 2003
The consequences of translational and rotational entropy lost by small molecules on binding to proteinsChristopher W Murray, Marcel L Verdonk
Current Opinion in Structural Biology|May 18, 2010
Structural biology in fragment-based drug designChristopher W Murray, Tom L Blundell
Nature Reviews. Chemistry|January 31, 2025
Return to FlatlandIan Churcher, Stuart Newbold, Christopher W Murray
Drug Discovery Today|July 5, 2005
Structural biology and drug discoveryMiles Congreve, Christopher W Murray, Tom L Blundell
Pain|February 1, 1991
Neurokinin and NMDA antagonists (but not a kainic acid antagonist) are antinociceptive in the mouse formalin modelChristopher W Murray, Alan Cowan, Alice A Larson
Nature Reviews. Genetics|October 18, 2018
Publisher Correction: Towards quantitative and multiplexed in vivo functional cancer genomicsIan P Winters, Christopher W Murray, Monte M Winslow
Nature Reviews. Genetics|September 30, 2018
Towards quantitative and multiplexed in vivo functional cancer genomicsIan P Winters, Christopher W Murray, Monte M Winslow
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Journal of Computer-Aided Molecular Design|May 27, 2011
Assessing the lipophilicity of fragments and early hitsPaul N Mortenson, Christopher W Murray
Angewandte Chemie (International Ed. in English)|November 4, 2015
Opportunity Knocks: Organic Chemistry for Fragment-Based Drug Discovery (FBDD)Christopher W Murray, David C Rees
Nature Chemistry|March 8, 2011
The rise of fragment-based drug discoveryChristopher W Murray, David C Rees
Journal of Computer-Aided Molecular Design|March 26, 2003
The consequences of translational and rotational entropy lost by small molecules on binding to proteinsChristopher W Murray, Marcel L Verdonk
Current Opinion in Structural Biology|May 18, 2010
Structural biology in fragment-based drug designChristopher W Murray, Tom L Blundell
Nature Reviews. Chemistry|January 31, 2025
Return to FlatlandIan Churcher, Stuart Newbold, Christopher W Murray
Drug Discovery Today|July 5, 2005
Structural biology and drug discoveryMiles Congreve, Christopher W Murray, Tom L Blundell
Pain|February 1, 1991
Neurokinin and NMDA antagonists (but not a kainic acid antagonist) are antinociceptive in the mouse formalin modelChristopher W Murray, Alan Cowan, Alice A Larson
Nature Reviews. Genetics|October 18, 2018
Publisher Correction: Towards quantitative and multiplexed in vivo functional cancer genomicsIan P Winters, Christopher W Murray, Monte M Winslow
Nature Reviews. Genetics|September 30, 2018
Towards quantitative and multiplexed in vivo functional cancer genomicsIan P Winters, Christopher W Murray, Monte M Winslow
Pageof 7